DEMIGOD:一个低成本的基于微控制器的闭环系统,集成纳米工程的基于汗液的葡萄糖监测和控制的超皮纳米乳液释放低血糖治疗的软件应用程序,用于非侵入性个性化糖尿病护理
Vasiliki Fiska1, Eirini Papanikolaou2, Michaela Patila3
1Department of Electrical and Computer Engineering, University of Western Macedonia, 50100 Kozani, Greece.
Micromachines
|July 27, 2024
概括
这项研究介绍了一种用于糖尿病管理的新型闭环系统,使用非侵入性汗水葡萄糖监测和纳米药物供应来精确控制血糖.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 糖尿病研究 糖尿病研究
背景情况:
- 糖尿病管理需要持续的葡萄糖监测,以实现最佳的血糖控制.
- 目前的监测方法可能对患者来说具有侵入性和负担.
- 开发非侵入性,自动化系统对于改善糖尿病护理至关重要.
研究的目的:
- 设计和开发一种用于糖尿病管理的创新的闭环诊断和治疗系统.
- 使用纳米工程生物传感器在汗水中实现非侵入性葡萄糖检测.
- 通过计算机控制的纳米药物输送系统,实现精确的治疗反应.
主要方法:
- 利用纳米工程屏幕打印生物传感器进行非侵入性汗水葡萄糖检测.
- 开发了一个专门的计算机系统 (硬件和软件) 用于数据管理和控制.
- 整合了一种基于贴片的纳米药物输送系统,用于通过皮肤进行低血糖治疗.
- 采用了纳米乳液的时空空测量结果和体内低血糖活性.
主要成果:
- 证明了从汗水中估计葡萄糖度的有效性和准确性.
- 验证了系统的决策机制,用于控制治疗反应.
- 证实了该系统提供的通过皮肤进行的低血糖治疗的有效性.
结论:
- 开发的闭环系统为非侵入性糖尿病管理提供了一个有希望的方法.
- 该系统准确估计葡萄糖水平,并提供精确的治疗干预措施.
- 这项技术有可能显著改善血糖控制和患者的生活质量.
相关概念视频
Hypoglycemia and Glucagon
229
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
229
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
Diabetes: Management and Pharmacotherapy
250
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
250
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K


